Home GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb
 

Keywords :   


GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb

2013-08-02 16:15:06| Biotech - Topix.net

The Intellectual Property Appellate Board has revoked the patent granted to the British drug major Glaxosmithkline Pharma Ltd for its breast cancer drug - Tykerb.

Tags: drug claim cancer patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.09Maxcess announces launch of new Tidland slitting system
25.09AkzoNobel Helps Consumer Electronics Industry to Use More Recycled Plastics
25.09Sherwin-Williams Interior Paint Earns Top Honors from J.D. Power
25.09Hurricane Helene Probabilistic Storm Surge Graphics
25.09 AkzoNobel Helps Consumer Electronics Industry to Use More Recycled Plastics
25.09Tnemec Announces New Technical Marketing Manager
25.09Petrol prices fall to lowest for three years
25.09Hurricane Helene Graphics
More »